Phyllom/Vestaron collaborate on bioinsecticides
The US biopesticide companies, Phyllom BioProducts (Oakland California) and Vestaron (Kalamazoo, Michigan), have entered into a research and development collaboration aimed at developing novel bioinsecticides. The companies are exploring "synergistic opportunities to control insect pests with potentially lower doses and better results", says Vestaron chief executive officer Dr John Sorenson. They expect that products derived from the collaboration will demonstrate advantages such as improved plant health and the control of difficult and resistant pests or disease vectors. Vestaron received US approval for its spider toxin-based bioinsecticide, Versitude (GS-omega/kappa-Hxtx-Hv1a), this year, with commercialisation scheduled for 2015 (Agrow No 682, p 26). Phyllom has recently introduced three Bacillus thuringiensis subsp galleriae-based bioinsecticides in the US (see this issue).